These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29581422)

  • 21. A fine-mapping study of 7 top scoring genes from a GWAS for major depressive disorder.
    Verbeek EC; Bakker IM; Bevova MR; Bochdanovits Z; Rizzu P; Sondervan D; Willemsen G; de Geus EJ; Smit JH; Penninx BW; Boomsma DI; Hoogendijk WJ; Heutink P
    PLoS One; 2012; 7(5):e37384. PubMed ID: 22649524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder.
    Zhong J; Li S; Zeng W; Li X; Gu C; Liu J; Luo XJ
    Neuropsychopharmacology; 2019 Aug; 44(9):1542-1551. PubMed ID: 30771789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large-scale whole-exome sequencing association study identifies FOXH1 gene and sphingolipid metabolism pathway influencing major depressive disorder.
    Zhou W; Chen L; Jiang B; Sun Y; Li M; Wu H; Zhang N; Sun X; Qin S
    CNS Neurosci Ther; 2021 Nov; 27(11):1425-1428. PubMed ID: 34633764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome-wide screening identifies novel rare risk variants for major depression disorder.
    Cheng S; Cheng B; Liu L; Yang X; Meng P; Yao Y; Pan C; Zhang J; Li C; Zhang H; Chen Y; Zhang Z; Wen Y; Jia Y; Zhang F
    Mol Psychiatry; 2022 Jul; 27(7):3069-3074. PubMed ID: 35365804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide Burden of Rare Short Deletions Is Enriched in Major Depressive Disorder in Four Cohorts.
    Zhang X; Abdellaoui A; Rucker J; de Jong S; Potash JB; Weissman MM; Shi J; Knowles JA; Pato C; Pato M; Sobell J; Smit JH; Hottenga JJ; de Geus EJC; Lewis CM; Buttenschøn HN; Craddock N; Jones I; Jones L; McGuffin P; Mors O; Owen MJ; Preisig M; Rietschel M; Rice JP; Rivera M; Uher R; Gejman PV; Sanders AR; Boomsma D; Penninx BWJH; Breen G; Levinson DF
    Biol Psychiatry; 2019 Jun; 85(12):1065-1073. PubMed ID: 31003785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder.
    Zhang Y; Li M; Wang Q; Hsu JS; Deng W; Ma X; Ni P; Zhao L; Tian Y; Sham PC; Li T
    Psychol Med; 2020 Feb; 50(3):384-395. PubMed ID: 30722798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resequencing three candidate genes for major depressive disorder in a Dutch cohort.
    Verbeek EC; Bevova MR; Bochdanovits Z; Rizzu P; Bakker IM; Uithuisje T; De Geus EJ; Smit JH; Penninx BW; Boomsma DI; Hoogendijk WJ; Heutink P
    PLoS One; 2013; 8(11):e79921. PubMed ID: 24278217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy.
    Clements CC; Karlsson R; Lu Y; Juréus A; Rück C; Andersson E; Boberg J; Pedersen NL; Bulik CM; Nordenskjöld A; Pålsson E; Sullivan PF; Landén M
    Mol Psychiatry; 2021 Jun; 26(6):2429-2439. PubMed ID: 33483693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare variants and biological pathways identified in treatment-refractory depression.
    McClain LL; Shaw P; Sabol R; Chedia AM; Segretti AM; Rengasamy M; Finegold DN; Pan L; Peters DG
    J Neurosci Res; 2020 Jul; 98(7):1322-1334. PubMed ID: 32128872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applying polygenic risk scores to postpartum depression.
    Byrne EM; Carrillo-Roa T; Penninx BW; Sallis HM; Viktorin A; Chapman B; Henders AK; ; Pergadia ML; Heath AC; Madden PA; Sullivan PF; Boschloo L; van Grootheest G; McMahon G; Lawlor DA; Landén M; Lichtenstein P; Magnusson PK; Evans DM; Montgomery GW; Boomsma DI; Martin NG; Meltzer-Brody S; Wray NR
    Arch Womens Ment Health; 2014 Dec; 17(6):519-28. PubMed ID: 25037970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder.
    Xiao X; Zheng F; Chang H; Ma Y; Yao YG; Luo XJ; Li M
    Neuropsychopharmacology; 2018 Apr; 43(5):1128-1137. PubMed ID: 28990594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Combined Pathway and Regional Heritability Analysis Indicates NETRIN1 Pathway Is Associated With Major Depressive Disorder.
    Zeng Y; Navarro P; Fernandez-Pujals AM; Hall LS; Clarke TK; Thomson PA; Smith BH; Hocking LJ; Padmanabhan S; Hayward C; MacIntyre DJ; Wray NR; ; Deary IJ; Porteous DJ; Haley CS; McIntosh AM
    Biol Psychiatry; 2017 Feb; 81(4):336-346. PubMed ID: 27422368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide gene-environment interaction in depression: A systematic evaluation of candidate genes: The childhood trauma working-group of PGC-MDD.
    Van der Auwera S; Peyrot WJ; Milaneschi Y; Hertel J; Baune B; Breen G; Byrne E; Dunn EC; Fisher H; Homuth G; Levinson D; Lewis C; Mills N; Mullins N; Nauck M; Pistis G; Preisig M; Rietschel M; Ripke S; Sullivan P; Teumer A; Völzke H; ; Boomsma DI; Wray NR; Penninx B; Grabe H
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):40-49. PubMed ID: 29159863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between TPH2 gene polymorphisms with major depressive disorder in multiethnic Malaysian population.
    Nazree NE; Loke AC; Zainal NZ; Mohamed Z
    Asia Pac Psychiatry; 2015 Mar; 7(1):72-7. PubMed ID: 24376086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Influences on Evening Preference Overlap with Those for Bipolar Disorder in a Sample of Mexican Americans and American Indians.
    Melroy-Greif WE; Gizer IR; Wilhelmsen KC; Ehlers CL
    Twin Res Hum Genet; 2017 Dec; 20(6):499-510. PubMed ID: 29192581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel strategy for clustering major depression individuals using whole-genome sequencing variant data.
    Yu C; Baune BT; Licinio J; Wong ML
    Sci Rep; 2017 Mar; 7():44389. PubMed ID: 28287625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study combining whole-exome sequencing and structural neuroimaging analysis for major depressive disorder.
    Han KM; Han MR; Kim A; Kang W; Kang Y; Kang J; Tae WS; Cho Y; Ham BJ
    J Affect Disord; 2020 Feb; 262():31-39. PubMed ID: 31706157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic predisposition to advanced biological ageing increases risk for childhood-onset recurrent major depressive disorder in a large UK sample.
    Michalek JE; Kepa A; Vincent J; Frissa S; Goodwin L; Hotopf M; Hatch SL; Breen G; Powell TR
    J Affect Disord; 2017 Apr; 213():207-213. PubMed ID: 28233563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.
    Haenisch B; Herms S; Mattheisen M; Steffens M; Breuer R; Strohmaier J; Degenhardt F; Schmäl C; Lucae S; Maier W; Rietschel M; Nöthen MM; Cichon S
    J Affect Disord; 2013 Apr; 146(3):438-40. PubMed ID: 22921522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.